Valion Bio, Inc. (VBIO) Return on equity 2021–2024
Valion Bio, Inc. (VBIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-223.1%FY2024 · since FY2021: -64.0% → -223.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -223.1% | +7.2 pp |
| FY2023 | -230.3% | +47.8 pp |
| FY2022 | -278.1% | -214.1 pp |
| FY2021 | -64.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice